[breadcrumb_custom]

Analyzing the Impact of Earnings Reports on Cadrenal Therapeutics Inc Inc. (CVKD) Price Performance

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 37.86% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 37.74%. Over the past 30 days, the price of CVKD has fallen by 54.55%. And in the last five days, it has fallen by -24.44%.

In terms of market performance, Cadrenal Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $3.14 on 07/12/23, while the lowest value was $0.40 on 11/07/23.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

52-week price history of CVKD Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Cadrenal Therapeutics Inc’s current trading price is -67.52% away from its 52-week high, while its distance from the 52-week low is 158.23%. The stock’s price range for this period has been between $0.40 and $3.14. The Healthcare sector company’s shares saw a trading volume of about 316.62 for the day, which was higher than the average daily volume of 2.11 over the last three months.

The Connection Between Financial Performance and Market Capitalization

Cadrenal Therapeutics Inc (CVKD) has experienced a quarterly rise of 119.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.28M.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6871, with a change in price of +0.3000. Similarly, Cadrenal Therapeutics Inc recorded 212,413 in trading volume during the last 100 days, posting a change of +41.67%.

CVKD’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CVKD stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

CVKD Stock Stochastic Average

As of today, the raw stochastic average of Cadrenal Therapeutics Inc over the past 50 days is 33.53%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 24.83%. Additionally, the Stochastic %K and %D values for the company were 26.11% and 34.46%, respectively, over the past 20 days.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts